NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
11/29/2025
Back to search
Official data from USPTO
EMPIRICO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
11/30/2025
Trademark type
Word
Nice classes
42
Filing date
12/31/2018
Registration date
07/21/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/29/2025
Last transaction
11/30/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
2018-12-00
First use in commerce
2018-12-00
Drawing code
4
Owner type
03
Owner location
San Diego, CA
Examiner
MUCHA,JOHN EVAN
Current location
Historical data usage
Holders and representatives
Holders
Empirico Inc.
Representatives
Chelsea E. Carbone WILSON SONSINI GOODRICH & ROSATI
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical research in connection with human genetics and programmable biology; pharmaceutical research in the fields of angiologycardiologyendocrinologygastroenterologygeriatricshematologyhepatologynephrologyneurologyoncologypulmonologypneumologyrespirologyrheumatologyanesthesiologyurologydermatologygynecologyophthalmologyinfectiologypsychiatry; pharmaceutical research in the fields of pediatricgeriatricemergencyfamilypreventative medicine; pharmaceutical research in the field of treatment of infectiousdeficiencyhereditaryphysiological diseases; medical research in connection with various diseases and disordersincluding eosinophilic diseasesasthmaCRSallergic rhinitisautoimmune diseasesincluding psoriasisvitiligolichen planusocular diseasesincluding intraocular pressure and glaucomaatopic dermatitis
Publications
History of USPTO decisions and trademark events.
34 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
11/29/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/29/2025
ES8R
TEAS SECTION 8 RECEIVED
07/29/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/21/2025
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
07/21/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/17/2020
ALIE
ASSIGNED TO LIE
06/10/2020
ALIE
ASSIGNED TO LIE
06/02/2020
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
05/28/2020
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
05/27/2020
IUAA
USE AMENDMENT ACCEPTED
05/27/2020
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
04/28/2020
DPCC
DIVISIONAL PROCESSING COMPLETE
04/28/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/28/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/07/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/06/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/06/2020
IUAF
USE AMENDMENT FILED
04/03/2020
DRRR
DIVISIONAL REQUEST RECEIVED
04/03/2020
EAAU
TEAS AMENDMENT OF USE RECEIVED
04/03/2020
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
04/03/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/08/2019
GNRT
NON-FINAL ACTION E-MAILED
10/08/2019
CNRT
NON-FINAL ACTION WRITTEN
10/08/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/13/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/12/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/12/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/20/2019
GNRT
NON-FINAL ACTION E-MAILED
03/20/2019
CNRT
NON-FINAL ACTION WRITTEN
03/20/2019
DOCK
ASSIGNED TO EXAMINER
03/20/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/23/2019
NWAP
NEW APPLICATION ENTERED
01/03/2019
Continuous trademark protection
Get notified about every new filing that threatens EMPIRICO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.